Most Active Biotech Investors in Berkeley 2026

7 firms writing Biotech checks in Berkeley, led by Atlas Venture, 5AM Ventures, Celesta Capital — ranked by verified deal count with the companies behind each.

Biotech in Berkeley accounts for 5 tracked companies with verified cap-table data, 5 of which disclose round sizes totalling $318M. The median disclosed raise is $55M, and the largest is Aeovian Pharmaceuticals at $105M, ahead of Azalea Therapeutics ($82M) and Renasant Bio ($55M).

The names that recur most often on these biotech cap tables are Luma Group (1 company), Hevolution (1 company), Third Rock Ventures (1 company), RA Capital Management (1 company), Yosemite (1 company), Sozo Ventures (1 company). By latest disclosed round, the market skews Series B (2), Series A (1), Seed (1), Series C (1).

Best funded Biotech in Berkeley companies

  1. Aeovian Pharmaceuticals — $105M (latest: Series B)
  2. Azalea Therapeutics — $82M (latest: Series A)
  3. Renasant Bio — $55M (latest: Seed)
  4. Caribou Biosciences — $40M (latest: Series C)
  5. Shiru — $36M (latest: Series B)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library